SOAT1 methylation is associated with coronary heart disease
- PMID: 31684966
- PMCID: PMC6829990
- DOI: 10.1186/s12944-019-1138-9
SOAT1 methylation is associated with coronary heart disease
Abstract
Background: This study was designed to investigate whether differential DNA methylationin of cholesterol absorption candidate genes can function as a biomarker for patients with coronary heart disease (CHD).
Methods: DNA methylation levels of the candidate genes FLOT1, FLOT2 and SOAT1 were measured in peripheral blood leukocytes (PBLs) from 99 patients diagnosed with CHD and 89 control subjects without CHD. A total of 110 CPG sites around promoter regions of them were examined.
Results: Compared with groups without CHD, patients with CHD had lower methylation levels of SOAT1 (P<0.001). When each candidate genes were divided into different target segments, patients with CHD also had lower methylation levels of SOAT1 than patients without (P = 0.005). After adjustment of other confounders, methylation levels of SOAT1 were still associated with CHD (P = 0.001, OR = 0.290, 95% CI: 0.150-0.561).
Conclusions: SOAT1 methylation may be associated with development of CHD. Patients with lower methylation levels in SOAT1 may have increased risks for CHD. Further studies on the specific mechanisms of this relationship are necessary.
Keywords: Cholesterol absorption; Coronary heart disease; DNA methylation; SOAT1.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Hypomethylation of Interleukin-6 Promoter is Associated with the Risk of Coronary Heart Disease.Arq Bras Cardiol. 2016 Aug;107(2):131-6. doi: 10.5935/abc.20160124. Arq Bras Cardiol. 2016. PMID: 27627640 Free PMC article.
-
Association of GAL-8 promoter methylation levels with coronary plaque inflammation.Int J Cardiol. 2024 Apr 15;401:131782. doi: 10.1016/j.ijcard.2024.131782. Epub 2024 Jan 19. Int J Cardiol. 2024. PMID: 38246423
-
Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease.Circulation. 2019 Aug 20;140(8):645-657. doi: 10.1161/CIRCULATIONAHA.118.039357. Epub 2019 Aug 19. Circulation. 2019. PMID: 31424985 Free PMC article.
-
DNA methylation signatures of incident coronary heart disease: findings from epigenome-wide association studies.Clin Epigenetics. 2021 Oct 9;13(1):186. doi: 10.1186/s13148-021-01175-6. Clin Epigenetics. 2021. PMID: 34627379 Free PMC article. Review.
-
Precision epigenetics provides a scalable pathway for improving coronary heart disease care globally.Epigenomics. 2023 Aug;15(16):805-818. doi: 10.2217/epi-2023-0233. Epub 2023 Sep 13. Epigenomics. 2023. PMID: 37702023 Review.
Cited by
-
A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker.Oncol Res. 2023 Apr 10;31(2):193-205. doi: 10.32604/or.2023.027112. eCollection 2023. Oncol Res. 2023. PMID: 37304239 Free PMC article.
-
Roles and Mechanisms of DNA Methylation in Vascular Aging and Related Diseases.Front Cell Dev Biol. 2021 Jun 28;9:699374. doi: 10.3389/fcell.2021.699374. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34262910 Free PMC article. Review.
-
Regulatory roles of PIWI-interacting RNAs in cardiovascular disease.Am J Physiol Heart Circ Physiol. 2025 Apr 1;328(4):H991-H1004. doi: 10.1152/ajpheart.00833.2024. Epub 2025 Mar 6. Am J Physiol Heart Circ Physiol. 2025. PMID: 40048207 Free PMC article. Review.
-
piRNA-6426 increases DNMT3B-mediated SOAT1 methylation and improves heart failure.Aging (Albany NY). 2022 Mar 30;14(6):2678-2694. doi: 10.18632/aging.203965. Epub 2022 Mar 30. Aging (Albany NY). 2022. PMID: 35354120 Free PMC article.
-
Blood-Based DNA Methylation Biomarkers to Identify Risk and Progression of Cardiovascular Disease.Int J Mol Sci. 2025 Mar 6;26(5):2355. doi: 10.3390/ijms26052355. Int J Mol Sci. 2025. PMID: 40076974 Free PMC article. Review.
References
-
- Poh K-K, Ambegaonkar B, Baxter Carl A, et al. Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region: results from the Dyslipidemia International Study II. Eur J Prev Cardiol. 2018;25:1950–1963. doi: 10.1177/2047487318798927. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources